Heck Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$860K 224
2025
Q4
$860K Buy
+800
New +$765K 0.06% 116
2025
Q2
Sell
-56
Closed -$46.3K 227
2025
Q1
$46.3K Hold
56
0.01% 169
2024
Q4
$43.2K Hold
56
0.01% 162
2024
Q3
$49.6K Hold
56
0.01% 161
2024
Q2
$50.7K Sell
56
-4
-7% -$3.2K 0.01% 158
2024
Q1
$46.7K Buy
+60
New +$42.7K 0.01% 159

Other funds holding LLY

Heck Capital Advisors's LLY Position: Q1 2026 in Review

Heck Capital Advisors sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 800 shares — an estimated $860K sold.

Heck Capital Advisors first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $860K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Heck Capital Advisors reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Heck Capital Advisors sold 800 Eli Lilly shares in Q1 2026, an estimated $860K.
  • Heck Capital Advisors first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • Heck Capital Advisors's Eli Lilly position peaked at $860K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Heck Capital Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.